Virtus Fund Advisers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$171M Buy
1,459,618
+24,804
+2% +$2.8M 1.68% 2
2017
Q3
$163M Buy
1,434,814
+493,779
+52% +$57M 1.67% 1
2017
Q2
$116M Buy
941,035
+662,872
+238% +$78.6M 1.15% 5
2017
Q1
$33M Buy
278,163
+248,204
+828% +$28.1M 0.31% 143
2016
Q4
$3.01M Sell
29,959
-2,193
-7% -$235K 0.03% 268
2016
Q3
$4.07M Sell
32,152
-667
-2% -$82.4K 0.04% 254
2016
Q2
$3.85M Sell
32,819
-832
-2% -$94.2K 0.03% 257
2016
Q1
$3.49M Hold
33,651
0.03% 266
2015
Q4
$3.36M Sell
33,651
-674
-2% -$65.9K 0.03% 251
2015
Q3
$3.14M Sell
34,325
-12
-0% -$1.2K 0.03% 249
2015
Q2
$3.64M Sell
34,337
-26,562
-44% -$2.94M 0.03% 260
2015
Q1
$6.95M Buy
60,899
+84
+0.1% +$9.58K 0.05% 226
2014
Q4
$6.7M Buy
60,815
+1,949
+3% +$205K 0.05% 232
2014
Q3
$5.75M Sell
58,866
-1,549
-3% -$152K 0.04% 241
2014
Q2
$6.09M Buy
+60,415
New +$5.89M 0.04% 252

Other funds holding ZBH

Virtus Fund Advisers's ZBH Position: Q4 2017 in Review

Virtus Fund Advisers increased its Zimmer Biomet (ZBH) stake by 1.7% in Q4 2017, buying an estimated $2.8M and bringing the position to 1,459,618 shares worth $171M. The position accounts for 1.68% of the portfolio, ranked #2.

Virtus Fund Advisers first reported a position in ZBH in Q2 2014 and has held it in 15 quarters since. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

  • Virtus Fund Advisers held 1,459,618 shares of Zimmer Biomet worth $171M as of Q4 2017.
  • Virtus Fund Advisers bought 24,804 Zimmer Biomet shares in Q4 2017, an estimated $2.8M.
  • Zimmer Biomet made up 1.68% of Virtus Fund Advisers's portfolio in Q4 2017, its #2 holding.
  • Virtus Fund Advisers first reported a position in Zimmer Biomet in Q2 2014 and has held it in 15 quarters since.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.